Guardant Health, Inc. (GH) Financials

GH Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.8 billion 1.6 billion
2023-09-30 1.8 billion 1.6 billion
2023-06-30 1.8 billion 1.5 billion
2023-03-31 1.5 billion 1.6 billion

GH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -82.8 million 24.3 million
2023-09-30 -80.2 million 21.8 million
2023-06-30 -100.5 million 22.4 million
2023-03-31 -82.0 million 22.3 million

GH Net Income

No data available :(

GH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.2 billion - 213.8 million
2023-09-30 1.2 billion - 219.0 million
2023-06-30 1.2 billion 1.1 billion 198.2 million
2023-03-31 937.0 million 1.1 billion 204.9 million

GH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 118.5 million
2023-09-30 117.7 million
2023-06-30 108.8 million
2023-03-31 102.7 million

GH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 4.1 million 89.9 million 37.7 million 79.1 million
2023-09-30 2.4 million 93.9 million 36.2 million 68.9 million
2023-06-30 6.5 million 90.4 million 41.5 million 71.0 million
2023-03-31 7.5 million 93.1 million 40.4 million 76.1 million

GH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 155.1 million -81.1 million
2023-09-30 143.0 million 57.6 million
2023-06-30 137.2 million 53.8 million
2023-03-31 128.7 million 53.1 million

GH

Price: $18.88

52 week price:
16.07
41.06

Earnings Per Share: -4.28 USD

P/E Ratio: -5.56

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 409714

Market Capitalization: 2.2 billion

Links: